Masakazu Fukushima

Effect of consecutive lower-dose cisplatin in enhancement of 5-fluorouracil cytotoxicity in experimental tumor cells in vivo.

M. Fukushima, Y. Kamiyama, H. Araki, 2000, Cancer letters.

Possible regulation of 5-fluorouracil-induced neuro- and oral toxicities by two biochemical modulators consisting of S-1, a new oral formulation of 5-fluorouracil.

M. Fukushima, J. Uchida, T. Shirasaka, 2001, Anticancer research.

Enhancement of the antitumour activity of 5-fluorouracil (5-FU) by inhibiting dihydropyrimidine dehydrogenase activity (DPD) using 5-chloro-2,4-dihydroxypyridine (CDHP) in human tumour cells.

A. Fujioka, M. Fukushima, E. Matsushima, 2002, European journal of cancer.

Preclinical antitumor efficacy of S-1: a new oral formulation of 5-fluorouracil on human tumor xenografts.

A. Fujioka, M. Fukushima, J. Uchida, 1998, International journal of oncology.

The history, mechanism and clinical use of oral 5-fluorouracil derivative chemotherapeutic agents.

M. Fukushima, H. Wada, F. Tanaka, 2000, Current pharmaceutical biotechnology.